| Literature DB >> 33021683 |
Thomas Rimmelé1,2, Léa Pascal3,4, Stéphanie Polazzi3,4, Antoine Duclos5,6.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 33021683 PMCID: PMC7537377 DOI: 10.1007/s00134-020-06249-2
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440
Factors associated with ICU mortality among COVID-19 patients
| Unadjusted | Adjusted | |||
|---|---|---|---|---|
| Factors | Relative risks (95% CI) | Relative risks (95% CI) | ||
| Weekend | 1.65 (1.54–1.77) | < 0.001 | 1.54 (1.45–1.64) | < 0.001 |
| Other weekdays | 1 | Reference | 1 | Reference |
| Paris region | 1.59 (1.3–1.95) | < 0.001 | 1.62 (1.35–1.94) | < 0.001 |
| Northeast | 1.35 (1.1–1.68) | 0.005 | 1.24 (1.02–1.49) | 0.029 |
| Northwest | 1.07 (0.83–1.37) | 0.604 | 1.14 (0.93–1.4) | 0.194 |
| Southeast | 1.28 (1.03–1.58) | 0.024 | 1.11 (0.93–1.33) | 0.258 |
| Southwest | 1 | Reference | 1 | Reference |
| Very high [44–229 patients] | 0.82 (0.74–0.9) | < 0.001 | 0.97 (0.86–1.1) | 0.664 |
| High [20–43 patients] | 0.86 (0.79–0.94) | 0.001 | 0.98 (0.9–1.07) | 0.661 |
| Low [8–19 patients] | 0.88 (0.81–0.96) | 0.004 | 0.94 (0.87–1.02) | 0.147 |
| Very low [0–7 patients] | 1 | Reference | 1 | Reference |
| April 13 to April 26 | 0.88 (0.76–1.02) | 0.092 | 1.14 (0.97–1.35) | 0.113 |
| March 30 to April 12 | 0.72 (0.65–0.8) | < 0.001 | 1.01 (0.89–1.15) | 0.873 |
| March 16 to March 29 | 0.81 (0.73–0.9) | < 0.001 | 1.08 (0.97–1.2) | 0.164 |
| January 01 to March 15 | 1 | Reference | 1 | Reference |
| Male | 1.06 (0.99–1.13) | 0.080 | 1.04 (0.98–1.09) | 0.229 |
| Female | 1 | Reference | 1 | Reference |
| 80+ | 5.38 (3.62–8) | < 0.001 | 3.92 (2.96–5.2) | < 0.001 |
| 75–79 | 3.91 (2.64–5.78) | < 0.001 | 2.77 (2.11–3.64) | < 0.001 |
| 70–74 | 2.96 (2.01–4.35) | < 0.001 | 2.12 (1.61–2.78) | < 0.001 |
| 60–69 | 2.36 (1.6–3.48) | < 0.001 | 1.78 (1.37–2.3) | < 0.001 |
| 40–59 | 1.34 (0.92–1.95) | 0.127 | 1.17 (0.91–1.51) | 0.218 |
| 18–39 | 1 | Reference | 1 | Reference |
| Very high [56–120] | 3.03 (2.66–3.44) | < 0.001 | 1.79 (1.6–2.01) | < 0.001 |
| High [43–55] | 2.12 (1.87–2.4) | < 0.001 | 1.39 (1.25–1.55) | < 0.001 |
| Low [33–42] | 1.65 (1.46–1.88) | < 0.001 | 1.27 (1.13–1.42) | < 0.001 |
| Very low [15–32] | 1 | Reference | 1 | Reference |
| 3+ | 1.36 (1.36–1.51) | < 0.001 | 1.03 (0.94–1.13) | 0.553 |
| 2 | 1.15 (1.15–1.27) | 0.010 | 0.96 (0.89–1.05) | 0.403 |
| 1 | 1.3 (1.17–1.43) | < 0.001 | 1.07 (0.97–1.18) | 0.179 |
| 0 | 1 | Reference | 1 | Reference |
| Yes | 2.1 (1.84–2.4) | < 0.001 | 1.60 (1.42–1.8) | < 0.001 |
| No | 1 | Reference | 1 | Reference |
| Yes | 2.23 (2.07–2.4) | < 0.001 | 1.84 (1.72–1.97) | < 0.001 |
| No | 1 | Reference | 1 | Reference |
| Very low [11,726–18,115] | 1.19 (1.1–1.28) | < 0.001 | 1.23 (1.14–1.33) | < 0.001 |
| Low [18,125–20,083] | 1.11 (1.01–1.22) | 0.025 | 1.12 (1.03–1.22) | 0.009 |
| High [20,083–22,582] | 1.08 (0.99–1.18) | 0.094 | 1.11 (1.03–1.2) | 0.009 |
| Very high [22,583–43,350] | 1 | Reference | 1 | Reference |
9809 critically ill COVID-19 patients from 350 hospitals were analyzed. Using modified Poisson regression model (with a robust error variance) accounting for patient clustering within hospitals and for patient related confounders (sex, age, SAPS II, Charlson comorbidity index, hemodynamic support, renal replacement therapy, patient median household income) and the date of patient ICU admission, we estimated adjusted relative risks with their 95% confidence intervals (95% CI)
aCategorized into quartiles